Manhattan Bridge Capital - LOAN Stock Forecast, Price & News

Manhattan Bridge Capital's stock was trading at $5.50 at the beginning of 2022. Since then, LOAN shares have increased by 1.8% and is now trading at $5.60.
View the best growth stocks for 2022 here.

Manhattan Bridge Capital saw a drop in short interest in July. As of July 15th, there was short interest totaling 5,800 shares, a drop of 58.0% from the June 30th total of 13,800 shares. Based on an average daily trading volume, of 25,200 shares, the short-interest ratio is presently 0.2 days. Currently, 0.1% of the shares of the stock are sold short.
View Manhattan Bridge Capital's Short Interest.

Manhattan Bridge Capital is scheduled to release its next quarterly earnings announcement on Wednesday, October 19th 2022.
View our LOAN earnings forecast.

Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) released its earnings results on Friday, March, 11th. The credit services provider reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by $0.01. Manhattan Bridge Capital had a trailing twelve-month return on equity of 11.51% and a net margin of 66.36%.

Manhattan Bridge Capital announced a quarterly dividend on Thursday, July 28th. Investors of record on Tuesday, October 11th will be paid a dividend of $0.125 per share on Monday, October 17th. This represents a $0.50 annualized dividend and a dividend yield of 8.93%. The ex-dividend date is Friday, October 7th.
Read our dividend analysis for LOAN.

Manhattan Bridge Capital (NASDAQ:LOAN) pays an annual dividend of $0.50 per share and currently has a dividend yield of 8.96%. LOAN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 113.64%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for LOAN.

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Bridge Capital investors own include Allena Pharmaceuticals (ALNA), Energy Transfer (ET), AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), B&G Foods (BGS), Enterprise Products Partners (EPD), Global Medical REIT (GMRE), Kimco Realty (KIM), Mylan (MYL) and Rigel Pharmaceuticals (RIGL).

Manhattan Bridge Capital trades on the NASDAQ under the ticker symbol "LOAN."

Manhattan Bridge Capital's stock is owned by many different institutional and retail investors. Top institutional shareholders include Shufro Rose & Co. LLC (1.69%), Bellwether Advisors LLC (1.09%), Blooom Inc. (0.65%), Clear Creek Financial Management LLC (0.47%), Hardy Reed LLC (0.41%) and Fi3 FINANCIAL ADVISORS LLC (0.39%). Insiders that own company stock include Assaf Ran, Eran Goldshmit, Lyron L Bentovim, Michael Jackson and Vanessa Kao.
View institutional ownership trends.

Shares of LOAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LOAN stock can currently be purchased for approximately $5.60.

Manhattan Bridge Capital (NASDAQ:LOAN) has a market capitalization of $64.37 million and generates $6.81 million in revenue each year. The credit services provider earns $4.42 million in net income (profit) each year or $0.44 on an earnings per share basis.

Manhattan Bridge Capital employs 6 workers across the globe.

Manhattan Bridge Capital's mailing address is 60 CUTTER MILL RD. SUITE 205, GREAT NECK NY, 11021. The official website for the company is www.manhattanbridgecapital.com. The credit services provider can be reached via phone at (516) 444-3400 or via fax at 516-444-3404.